Location · Reno, NV
Clinical trials in Reno, NV
48 recruiting studies have a site in Reno, and 8 of them accept healthy volunteers.
48 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Hoffmann-La Roche
- Location
- Reno, NV + 52 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
GlaxoSmithKline
- Location
- Reno, NV + 36 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 4
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Amgen
- Location
- Reno, NV + 57 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 2/Phase 3
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Janssen Research & Development, LLC
- Location
- Reno, NV + 44 other US sites
- Eligibility basics
- Ages 60+
- Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
C. R. Bard
- Location
- Reno, NV + 32 other US sites
- Eligibility basics
- Ages 22–70 · Women only
- Recruiting
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
SoniVie Inc.
- Location
- Reno, NV + 33 other US sites
- Eligibility basics
- Ages 22–75
- RecruitingPhase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Eli Lilly and Company
- Location
- Reno, NV + 120 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
Calcilytix Therapeutics, Inc., a BridgeBio company
- Location
- Reno, NV + 3 other US sites
- Eligibility basics
- Ages 16+
- Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
VIVEX Biologics, Inc.
- Location
- Reno, NV + 18 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Reno, NV + 55 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice…
Eli Lilly and Company
- Location
- Reno, NV + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
ADARx Pharmaceuticals, Inc.
- Location
- Reno, NV + 18 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Apollo Therapeutics Ltd
- Location
- Reno, NV + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Reno, NV + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics
- Location
- Reno, NV + 19 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Reno, NV + 111 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Reno, NV + 57 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Reno, NV + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 1/Phase 2
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
AbbVie
- Location
- Reno, NV + 4 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Ardelyx
- Location
- Reno, NV + 108 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteers
Quality of End-of-Life Care for Children With Cancer
Children's Oncology Group
- Location
- Reno, NV + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
The Social Regulation of Threat-related Vigilance and Arousal
University of Nevada, Reno
- Location
- Reno, NV
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol
Cardio Surgical Partners
- Location
- Reno, NV
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
Pacific Research Institute
- Location
- Reno, NV + 8 other US sites
- Eligibility basics
- Ages 18+